
|Articles|July 1, 2003
ISTA begins phase III study of bromfenac
ISTA Pharmaceuticals Inc. has filed an investigational new drug application with the FDA to begin a phase III study of bromfenac.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants single-patient expanded access for urcosimod in neuropathic corneal pain
2
Q&A: What’s in the glaucoma treatment pipeline?
3
Sneak peek: What’s ahead at the second International Glaucoma Symposium in Mainz, Germany
4
What attendees can learn in a day: 2nd International Glaucoma Symposium
5



























